Astellas Pharma Inc. total revenue, net income and dynamics of changes in US dollar today
The dynamics of Astellas Pharma Inc. net revenue has changed by -16 806 000 000 $ over the last period. The dynamics of Astellas Pharma Inc. net income went down. The change was -72 407 000 000 $. Net income, revenue and dynamics - the main financial indicators of Astellas Pharma Inc.. Astellas Pharma Inc. net income is shown in blue on the graph. All information on Astellas Pharma Inc. total revenue on this chart is created in the form of yellow bars. A graph of the value of all Astellas Pharma Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
308 621 000 000 $
+2.42 % ↑
-12 328 000 000 $
-140.1171 % ↓
31/12/2020
325 427 000 000 $
-3.738 % ↓
60 079 000 000 $
-2.301 % ↓
30/09/2020
308 512 000 000 $
-2.473 % ↓
22 425 000 000 $
-67.968 % ↓
30/06/2020
306 969 000 000 $
-8.13 % ↓
50 413 000 000 $
-13.85 % ↓
31/12/2019
338 065 000 000 $
-
61 494 000 000 $
-
30/09/2019
316 336 000 000 $
-
70 009 000 000 $
-
30/06/2019
334 134 000 000 $
-
58 518 000 000 $
-
31/03/2019
301 320 000 000 $
-
30 730 000 000 $
-
31/12/2018
357 932 000 000 $
-
87 669 000 000 $
-
30/09/2018
318 011 000 000 $
-
49 307 000 000 $
-
30/06/2018
329 085 000 000 $
-
54 559 000 000 $
-
Show:
to
Astellas Pharma Inc. financial report charts
Dates of Astellas Pharma Inc. finance reports: 30/06/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Astellas Pharma Inc. for today is 31/03/2021. Gross profit Astellas Pharma Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Astellas Pharma Inc. is 250 294 000 000 $
Astellas Pharma Inc. quarterly report dates
Cost of revenue Astellas Pharma Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Astellas Pharma Inc. is 58 327 000 000 $ Total revenue Astellas Pharma Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Astellas Pharma Inc. is 308 621 000 000 $ Operating income Astellas Pharma Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Astellas Pharma Inc. is 91 197 000 000 $
Net income Astellas Pharma Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Astellas Pharma Inc. is -12 328 000 000 $ Current assets Astellas Pharma Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Astellas Pharma Inc. is 872 588 000 000 $ Total assets Astellas Pharma Inc. refers to the total amount of assets owned by a person or entity. Total assets Astellas Pharma Inc. is 2 273 628 000 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
250 294 000 000 $
257 240 000 000 $
248 616 000 000 $
247 315 000 000 $
255 295 000 000 $
247 976 000 000 $
263 622 000 000 $
236 981 000 000 $
273 761 000 000 $
245 207 000 000 $
258 349 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
58 327 000 000 $
68 187 000 000 $
59 896 000 000 $
59 654 000 000 $
82 770 000 000 $
68 360 000 000 $
70 512 000 000 $
64 339 000 000 $
84 171 000 000 $
72 804 000 000 $
70 736 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
308 621 000 000 $
325 427 000 000 $
308 512 000 000 $
306 969 000 000 $
338 065 000 000 $
316 336 000 000 $
334 134 000 000 $
301 320 000 000 $
357 932 000 000 $
318 011 000 000 $
329 085 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
91 197 000 000 $
72 595 000 000 $
26 301 000 000 $
60 841 000 000 $
76 154 000 000 $
85 788 000 000 $
77 815 000 000 $
71 943 000 000 $
83 030 000 000 $
63 643 000 000 $
63 801 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-12 328 000 000 $
60 079 000 000 $
22 425 000 000 $
50 413 000 000 $
61 494 000 000 $
70 009 000 000 $
58 518 000 000 $
30 730 000 000 $
87 669 000 000 $
49 307 000 000 $
54 559 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
55 668 000 000 $
57 120 000 000 $
54 412 000 000 $
57 288 000 000 $
54 780 000 000 $
51 467 000 000 $
53 507 000 000 $
58 723 000 000 $
50 393 000 000 $
47 433 000 000 $
52 132 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
217 424 000 000 $
252 832 000 000 $
282 211 000 000 $
246 128 000 000 $
261 911 000 000 $
230 548 000 000 $
256 319 000 000 $
229 377 000 000 $
274 902 000 000 $
254 368 000 000 $
265 284 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
872 588 000 000 $
863 294 000 000 $
819 902 000 000 $
795 979 000 000 $
834 150 000 000 $
855 596 000 000 $
820 130 000 000 $
857 159 000 000 $
890 258 000 000 $
845 514 000 000 $
844 734 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 273 628 000 000 $
2 296 843 000 000 $
2 237 016 000 000 $
2 256 035 000 000 $
1 989 779 000 000 $
1 979 816 000 000 $
1 927 031 000 000 $
1 897 648 000 000 $
1 928 325 000 000 $
1 886 926 000 000 $
1 866 551 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
326 128 000 000 $
306 514 000 000 $
286 734 000 000 $
239 934 000 000 $
277 602 000 000 $
311 367 000 000 $
259 422 000 000 $
311 074 000 000 $
331 296 000 000 $
306 867 000 000 $
309 741 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
466 058 000 000 $
483 626 000 000 $
464 162 000 000 $
495 759 000 000 $
494 592 000 000 $
447 580 000 000 $
438 647 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
672 333 000 000 $
683 681 000 000 $
677 323 000 000 $
639 252 000 000 $
636 116 000 000 $
604 241 000 000 $
590 630 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
33.79 %
34.53 %
35.15 %
33.69 %
32.99 %
32.02 %
31.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 386 115 000 000 $
1 368 609 000 000 $
1 329 628 000 000 $
1 306 684 000 000 $
1 317 446 000 000 $
1 296 135 000 000 $
1 249 708 000 000 $
1 258 396 000 000 $
1 292 209 000 000 $
1 282 685 000 000 $
1 275 921 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
68 631 000 000 $
94 247 000 000 $
7 412 000 000 $
54 949 000 000 $
91 595 000 000 $
74 907 000 000 $
37 179 000 000 $
Last revenue report of Astellas Pharma Inc. was 31/03/2021. According to last financial report total revenue in Astellas Pharma Inc. was 308 621 000 000 US dollar and changed by +2.42% since last year. Net income in Astellas Pharma Inc. was -12 328 000 000 $ in last quartal, net income changes to -140.1171%.
Current cash Astellas Pharma Inc. - the sum of all of the cash a company has on the date of report. Current cash Astellas Pharma Inc. is 326 128 000 000 $
Astellas Pharma Inc. stocks data
ALPMY stock price
Astellas Pharma Inc. stock price today, ALPMY stock quote.
